Innovative treatments: the new frontier for mental health
In this exclusive piece, Adrien Châtillon, Co-Founder and CEO of Actipulse Neuroscience, explores the future of treatment for diseases that impact mental health.
List view / Grid view
In this exclusive piece, Adrien Châtillon, Co-Founder and CEO of Actipulse Neuroscience, explores the future of treatment for diseases that impact mental health.
Hormones that signal the body's state of hunger and fullness could be the key to new treatments for drug and alcohol addiction...
The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.
30 August 2016 | By Niamh Louise Marriott, Digital Content Producer
A research group has identified an enzyme, PRDM2, whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops...
5 August 2016 | By Indiana University
Using rats carefully bred to either drink large amounts of alcohol or to spurn it, researchers at Indiana and Purdue universities have identified hundreds of genes that appear to play a role in increasing the desire to drink alcohol...
9 December 2015 | By Victoria White
The discovery, made by scientists from the Salk Institute, could help the millions of people worldwide affected by liver fibrosis and cirrhosis, caused by alcoholism and diseases like hepatitis...